Insulin-like growth factor 1 (IGF1) is an important biomarker for the treatment of growth hormone disorders. Recently, there has been increased interest in using mass spectrometric (MS) detection methods to measure IGF1. However, widespread clinical deployment of an MS-based IGF1 assay requires increased throughput and speed to justify analysis costs, as well as robust industrial platforms that are reproducible across laboratories. Presented here is an MS-based quantitative IGF1 assay with a performance evaluation of >1,000 samples/day and an ability to … Continue reading „Human Insulin Like Growth Factor 1 (IGF1)“